Pacira BioSciences, Inc. (PCRX) NASDAQ
25.55
+1.04(+4.24%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
25.55
+1.04(+4.24%)
Currency In USD
| Market Cap | 1.15B |
| Enterprise Value | 1.45B |
| P/E Ratio | 154.34 |
| PEG Ratio | -3.22 |
| Price/Sales Ratio | 1.51 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 1.92 |
| Enterprise/EBITDA | 11.46 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
| Revenue | 726.41M |
| Revenue/Share | 17.1 |
| Gross Profit | 519.37M |
| EBITDA | 119.13M |
| Net Income | 7.03M |
| Diluted EPS | 0.16 |
| Total Cash | 238.42M |
| Total Cash/Share | 5.61 |
| Total Debt | 454.38M |
| Total Debt/Equity | 0.66 |
| Current Ratio | 4.54 |
| Book Value Per Share | 16.31 |
| 52-Week Change | -5.86 |
| 52-Week High | 27.64 |
| 52-Week Low | 18.8 |
| Moving Average 50 Days | 23.15 |
| Moving Average 200 Days | 23.59 |
| Average Volume | 722,016 |
| Shares Outstanding | 43.02M |
| % Held by Institutions | 107.15 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |